participant with lower face laxity lowercase laxity, Synchronized Radiofrequency and High-Intensity Focused Electric Stimulation
Conditions
Interventions
Participants with mild to moderate facial laxity will receive four sessions of Synchronized Radiofrequency and High-Intensity Focused Electrical Stimulation treatment, spaced one week apart. Follow-up
Experimental Device
Synchronized Radiofrequency and High-Intensity Focused Electric Stimulation
Sponsors
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. age 40-60 male and female 2. have mild to moderate degree of lower face laxity 3. Asian descent 4. agree to receive treatment and follow up as protocol
Exclusion criteria
Exclusion criteria: 1. Participants with a pacemaker. 2. Participants wearing braces. 3. Participants with prosthetic limbs or internal metal implants. 4. Pregnant women or those breastfeeding. 5. Participants with a history of abnormal platelet disorders or abnormal blood clotting, anemia, liver disease, cancer, autoimmune deficiency. 6. Participants who smoke and have a history of heavy alcohol consumption. 7. Participants with inflammatory skin rashes (dermatitis), wounds, or infected skin on the face. 8. Participants with a history of taking medications that affect blood clotting, such as aspirin and anticoagulants. 9. Participants with a history of facial lifting procedures, including lifting devices or thread lifting, within 6 months prior to joining the research project. 10. Participants who have had facial fillers injected within 6 months before joining the research project. 11. Participants who have had injections of concentrated platelet-rich plasma in the face within 6 months before joining the research project. 12. Participants who have had botulinum toxin injections in the face within 6 months before joining the research project. 13. Participants who have undergone facial collagen-stimulating laser treatments, such as Picosecond laser, Erbium: YAG laser, Fractora, or Laser E matrix within 6 months before joining the research project. 14. Participants with hypertrophic scars. 15. Participants with a diagnosed mental disorder by a psychiatrist. 16. Participants who do not consent to having photographs taken for treatment assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume change baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment Quantificare | — |
Secondary
| Measure | Time frame |
|---|---|
| wrinkle baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment antera,texture baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment antera,lifting vector baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment Quantificare,skin elasticity baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment cutometer,melanin baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment mexameter,erythema baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment mexameter,hydration baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment corneometer,patient assessment score baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment GAIS score,adverse event baseline, 2 weeks after 1st treatment( 3rd treatment), 1-,3- and 6 months after complete treatment note,pain score treatment 1, treatment 2, treatment 3, treatment 4 visual analog scale | — |
Countries
Thailand
Contacts
Public ContactWoraphong Manuskiatti
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed